Tumor metabolic heterogeneity based on ¹⁸F-FDG PET/CT is a predictor of outcome in diffuse large B-cell lymphoma.

ABSTRACT:

SUBMITTER: Xin W 

PROVIDER: S-EPMC12641985 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature